| Literature DB >> 20144351 |
Amanda Bartelme1, Perry Bridger.
Abstract
Continuous glucose monitors are a clinically meaningful addition to treatment plans for patients with diabetes who are actively managing their care. Since they first became commercially available, much progress has been made to ensure coverage of these devices for patients, but inadequate reimbursement of clinicians' time continues to serve as a barrier to adoption. Copyright 2009 Diabetes Technology Society.Entities:
Mesh:
Substances:
Year: 2009 PMID: 20144351 PMCID: PMC2769941 DOI: 10.1177/193229680900300449
Source DB: PubMed Journal: J Diabetes Sci Technol ISSN: 1932-2968